These can worsen GLP-1 side effects like nausea, reflux, and bloating
Semaglutide may be the better option if: Cost is the primary concern compounded semaglutide offers the most affordable path to GLP-1 therapy in 2026 You have cardiovascular disease the SELECT trial demonstrated significant reduction in major cardiovascular events with semaglutide, giving it the strongest CV evidence base of any GLP-1 medication
Patient Schooling: Give intensive directions to patients or guardians taking drugs stockpiling, dealing with, organization, and removal
Kelley added that other issues, including the duration of medication availability through TrumpRx, need to be resolved
[1] [11] mhra.gov.uk), which contributes to ongoing pharmacovigilance and patient safety
Food and Drug Administration (FDA) has approved an expanded indication for semaglutide as the first injectable antiobesity prescription medication for use in pediatric patients